Karolinska Development AB (publ) (STO:KDEV)

Market Cap	83.65M
Revenue (ttm)	1.74M
Net Income (ttm)	-135.74M
Shares Out	269.83M
EPS (ttm)	-0.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,174,425
Average Volume	913,599
Open	0.3025
Previous Close	0.3100
Day's Range	0.2990 - 0.3255
52-Week Range	0.2990 - 1.3440
Beta	0.54
RSI	32.07
Earnings Date	Feb 13, 2026

About Karolinska Development AB

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio com...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: KDEV